Page 2 - PaxGenBio Co., Ltd.
P. 2
COMPANY INTRODUCTION
About PaxGenBio
PaxGenBio Co., Ltd. was established in 2015 as a molecular diagnostics company
that develops, manufactures and markets a portfolio of IVD products targeting
infectious diseases and cancers.
PaxGenBio applies its proprietary, chimeric technologies that combine techniques for
molecular and immune diagnostics.
One of its proprietary technologies, MPCR-ULFA that combines multiplex PCR
amplification and universal lateral flow assay (ULFA) enables sensitive, specific, fast,
affordable and easy nucleic acid tests that are especially appropriate for applications
in low resource settings.
Certificate & Patent
Certificate of Brand Designation of GMP G-PASS Company Method and Kit for
K promising small and Detecting Target
medium-sized export Nucleic Acid_USA
companies
Certificate EU Certificate EU Certificate EU EN ISO13485 Certificate of
Product Notification Product Notification Product Notification Manufacturer
HPV SARS-CoV-2 TB/NTM
